Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- ACCJ White Paper Calls For Deregulations in Healthcare Services
August 20, 2001
- Bronchodilators Recommended for COPD: NBI Seminar
August 20, 2001
- Subcommittee Discusses Prices of Medical Materials
August 20, 2001
- Novo Nordisk: InnoLet, New Insulin Kit Targeted at the Elderly
August 20, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 20, 2001
- Fresenius to Supply Artificial Kidneys to Teijin
August 20, 2001
- Compounds under R&D by Japanese Makers in US Show Rapid Increases: JETRO Survey
August 20, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 20, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
August 6, 2001
- Kenporen to Cooperate with Nikkeiren, Rengo in Healthcare Reform
August 6, 2001
- CRO Business Expanding Rapidly: Association Report
August 6, 2001
- Chamber Councils Selection System to Be Started in Medical Malpractice Suits
August 6, 2001
- Kasamatsu Meiki, Hokuho Iyaku to Merge on Oct. 1
August 6, 2001
- WORLD NEW IN BRIEF
August 6, 2001
- Int'l Licensing Symposium to Be Held in Tokyo in September
August 6, 2001
- Gap between Boots and Mitsubishi Strategies Seen in Close of 4 Stores
August 6, 2001
- Development of Kissei's Rizaben Discontinued by GSK
August 6, 2001
- Sun Drug-Kawachi Yakuhin Alliance Likely to Be Successful: Security Analyst
August 6, 2001
- 3 Groups to Study How to Improve Supply of Drug Information
August 6, 2001
- BULLETIN
August 6, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…